UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.

Zajicek, J; Fox, P; Sanders, H; Wright, D; Vickery, J; Nunn, A; ... UK MS Research Group,; + view all (2003) Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet , 362 (9395) 1517 - 1526. 10.1016/S0140-6736(03)14738-1.

Full text not available from this repository.

Abstract

Multiple sclerosis is associated with muscle stiffness, spasms, pain, and tremor. Much anecdotal evidence suggests that cannabinoids could help these symptoms. Our aim was to test the notion that cannabinoids have a beneficial effect on spasticity and other symptoms related to multiple sclerosis.

Type:Article
Title:Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.
Location:England
DOI:10.1016/S0140-6736(03)14738-1
Language:English
Keywords:Cannabidiol, Cannabinoids, Dronabinol, Female, Great Britain, Humans, Locomotion, Male, Middle Aged, Multiple Sclerosis, Muscle Spasticity, Outcome Assessment (Health Care), Physical Examination, Placebos, Secondary Prevention, Treatment Outcome, Walking
UCL classification:UCL > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > MRC Clinical Trials Unit at UCL

Archive Staff Only: edit this record